×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

InsideArbitrage Event Driven Monitor – March 25, 2024

  • March 25, 2024

Merger Arbitrage

  1. MOR: On March 22, 2024, MorphoSys (MOR) and Novartis (NVSannounced that they have received the clearance of the U.S. antitrust under the HSR Act. The merger is expected to close in the first half of 2024.
  2. ORRF: On March 22, 2024, Orrstown Financial Services (ORRF)  and Codorus Valley Bancorp (CVLYfiled a definitive proxy statement. The Annual meeting of shareholders will be held on April 30, 2024.
  3. CBAY: The acquisition of CymaBay Therapeutics, Inc. (CBAY) by Gilead Sciences, Inc. (GILD) was completed on March 22, 2024. It took 39 days for this deal to be completed.

You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.

Only plus or premium subscribers can access this post. Subscribe today.